Review article · 2026 · Open access
Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases
Intractable & Rare Diseases Research, 15(2), 144–155 · Published 24 March 2026 · DOI 10.5582/irdr.2025.01057
In brief
“Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases” is a 2026 review article by Xing Fang and 4 co-authors, published in Intractable & Rare Diseases Research. OpenAlex counts 0 citations as of 20 November 2026. It is open access: the full text is free to read at Intractable & Rare Diseases Research.
- Citations
- 0
- References
- 70
- Authors
- 5
Abstract
Chimeric antigen receptor (CAR) T-cell therapy targeting B cells has emerged as a breakthrough treatment for hematological malignancies and shows promising potential in autoimmune diseases. While selective targeting of B-cell activation and autoantibody production represents an innovative therapeutic approach in autoimmune conditions, clinical responses remain suboptimal in many patients due to incomplete B-cell depletion in tissues and limitations in identifying ideal target antigens. Over the past four years, autologous or allogeneic CAR T-cell therapy has demonstrated remarkable efficacy in autoimmune diseases, achieving rapid and sustained B-cell depletion alongside complete clinical and serological remission. This review examines the current landscape of B cell-targeting CAR T-cell therapy, its therapeutic applications in autoimmune disorders, ongoing translational research, and future developments.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Fang, X., 魏锐利, Zhu, W., Hu, Y., & Liang, H. (2026). Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases. Intractable & Rare Diseases Research, 15(2), 144–155. https://doi.org/10.5582/irdr.2025.01057
MLA 9
Fang, Xing, et al. “Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases.” Intractable & Rare Diseases Research, vol. 15, no. 2, 2026, pp. 144–155. https://doi.org/10.5582/irdr.2025.01057.
Chicago
Fang, Xing, 魏锐利, Wenli Zhu, Yongxian Hu, and Hui Liang. 2026. “Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases.” Intractable & Rare Diseases Research 15 (2): 144–155. https://doi.org/10.5582/irdr.2025.01057.
Harvard
Fang, X. et al. (2026) ‘Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases’, Intractable & Rare Diseases Research, 15(2), pp. 144–155. doi:10.5582/irdr.2025.01057.
IEEE
X. Fang, 魏锐利, W. Zhu, Y. Hu, and H. Liang, “Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases,” Intractable & Rare Diseases Research, vol. 15, no. 2, pp. 144–155, 2026, doi: 10.5582/irdr.2025.01057.
BibTeX
@article{fang2026beyond,
title = {{Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases}},
author = {Fang, Xing and 魏锐利 and Zhu, Wenli and Hu, Yongxian and Liang, Hui},
journal = {Intractable \& Rare Diseases Research},
year = {2026},
volume = {15},
number = {2},
pages = {144--155},
doi = {10.5582/irdr.2025.01057},
url = {https://doi.org/10.5582/irdr.2025.01057}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- CAR T-cell therapy
- autoimmune disease
- B-cell depletion
- autoantibody production
- allogeneic CAR T cells
- autologous CAR T cells
- serological remission
- target antigen selection
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Fang, X., 魏锐利, Zhu, W., Hu, Y., & Liang, H. (2026). Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases. Intractable & Rare Diseases Research, 15(2), 144–155. https://doi.org/10.5582/irdr.2025.01057
How many times has this paper been cited?
0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Intractable & Rare Diseases Research: sign in and open the PDF from this page.
Who wrote this paper?
Xing Fang, 魏锐利, Wenli Zhu, Yongxian Hu, Hui Liang.
What is the DOI of this paper?
10.5582/irdr.2025.01057, permanently at https://doi.org/10.5582/irdr.2025.01057. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.